Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Evaluate IAH0968 in Combination With CAPEOX in a Phase II/III Clinical Study of HER2-positive Metastatic Colorectal Cancer

NCT05673512 is registered in ClinicalTrials.gov with SUNHO（China）BioPharmaceutical CO., Ltd. as lead sponsor.

NCT NCT05673512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05673512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Evaluate IAH0968 in Combination With CAPEOX in a Phase II/III Clinical Study of HER2-positive Metastatic Colorectal Cancer
Lead sponsor
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase
Phase 2/3
Overall status
Unknown status
Start date
May 12, 2023
Completion date
March 1, 2026
Enrollment
279 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

her2 gene mutation